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Abstract
Background: Kaposi’s sarcoma-associated herpesvirus (KSHV) glycoprotein B (gB) is not only expressed on the
envelope of mature virions but also on the surfaces of cells undergoing lytic replication. Among herpesviruses,
KSHV gB is the only glycoprotein known to possess the RGD (Arg-Gly-Asp) binding integrin domain critical to
mediating cell attachment. Recent studies described gB to also possess a disintegrin-like domain (DLD) said to
interact with non-RGD binding integrins. We wanted to decipher the roles of two individually distinct integrin
binding domains (RGD versus DLD) within KSHV gB in regulating attachment of cells over cell migration.
Methods: We established HeLa cells expressing recombinant full length gB, gB lacking a functional RGD (gBΔR),
and gB lacking a functionally intact DLD (gBΔD) on their cell surfaces. These cells were tested in wound healing
assay, Transwell migration assay, and adhesion assay to monitor the ability of the RGD and DLD integrin recognition
motifs in gB to mediate migration and attachment of cells. We also used soluble forms of the respective gB
recombinant proteins to analyze and confirm their effect on migration and attachment of cells. The results
from the above studies were authenticated by the use of imaging, and standard biochemical approaches as
Western blotting and RNA silencing using small interfering RNA.
Results: The present report provides the following novel findings: (i) gB does not induce cell migration; (ii) RGD
domain in KSHV gB is the switch that inhibits the ability of DLD to induce cellular migration thus promoting
attachment of cells.
Conclusions: Independently, RGD interactions mediate attachment of cells while DLD interactions regulate
migration of cells. However, when both RGD and DLD are functionally present in the same protein, gB, the RGD
interaction-induced attachment of cells overshadows the ability of DLD mediated signaling to induce migration
of cells. Furthering our understanding of the molecular mechanism of integrin engagement with RGD and DLD
motifs within gB could identify promising new therapeutic avenues and research areas to explore.
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Background
One of the hallmarks of cancer progression is cell attach-
ment, migration, and invasion [1–3]. All of these key fea-
tures are mediated by interactions with integrin-associated
signaling [4]. The most commonly described integrins are
those that recognize a small tripeptide amino acid se-
quence, RGD (Arg-Gly-Asp), and effectively mediate cell
attachment, migration, and invasion [5, 6]. Of late, a small
group of proteins referred to as disintegrins has also been
described to bind integrins [7]. Disintegrins are non-
enzymatic polypeptides broadly distributed in the venoms
of viperid snakes, which antagonize the functions of sev-
eral types of integrin receptors [8]. The minimum compo-
nent of the disintegrin module required for integrin
engagement is the 12- to 13-amino-acid disintegrin loop,
for which a consensus sequence has been described:
RX6DLXXF [9]. We hypothesized that RGD and
disintegrin-like domain (DLD) had distinct roles to play in
regulating attachment and migration of cells.
We employed Kaposi’s sarcoma-associated herpesvirus
(KSHV) encoded glycoprotein B (gB) in functional as-
says to test our hypothesis. KSHV gB possess both of the
aforementioned integrin binding domains. Among the α,
β, and γ herpesvirus gB sequenced to date, KSHV gB
possesses not only the RGD motif but also a functional
disintegrin-like domain (DLD) [10]. Both RGD (27-
29aa) and DLD (66-85aa) are placed juxtaposed in the
N-terminus ectodomain region of the gB. In the case of
KSHV gB, the DLD sequence is RX5-7D/ELXXF/LX5C
(66-85aa; with a conservative D to E substitution).
KSHV gB is not only expressed on the viral envelope but
also on the infected cell membranes [11]. Earlier studies
established the fact that soluble form and membrane as-
sociated full length gB could mediate cell attachment to
extracellular matrix protein (ECM)-coated wells or a
matrigel via binding to RGD-binding integrins [12]. In
the present study, we have attempted to answer the
following questions: (i) Does gB, a protein that possess
both RGD and DLD mediate migration of cells? (ii)
What are the distinct roles of RGD and DLD in promot-
ing attachment and migration of cells? We concluded
that the RGD and DLD interactions with integrins have
distinct roles in affecting the function of a protein. Our
study, for the first time describes RGD domain as a
switch that regulates function of DLD contained within
the same protein (gB) to effectively assist attachment of
cells versus migration. A short discussion on how these
divergent integrin-based interactions will alter KSHV
pathogenesis is also provided.
Methods
Cells
A human cervical cancer HeLa cell line, human umbilical
vein endothelial cells (HUVEC; Invitrogen, Carlsbad, CA),
and Spodoptera frugiperda ovarian cells (Sf9) were propa-
gated as per standard laboratory procedures [10, 13, 14].
Transfection of cells and silencing PIKfyve RNA (SiRNA)
To establish stably transfected HeLa cells expressing
different recombinant gB and gH proteins, cells (5x105
cells) were seeded onto 24 well plates. Post 24 h of
seeding, the cells were transfected with the respective
plasmid DNA using FuGENE HD transfection reagent
(Promega, Madison, WI). These cells were cultured in
selection medium containing 500 μg/ml of G418 from
the second day of transfection for a duration of
8 weeks after which the expression of genes encoding
different gB proteins were confirmed by flow cytome-
try and RT-PCR. At least 2 pools of cells/each plasmid
that were under the selection for about 8 weeks were
tested in our experiments. Expression of PIKfyve was
inhibited by the transfection of HeLa cells which were sta-
bly transfected to express gBΔR with double-stranded
RNA oligonucleotides as described previously [15, 16].
The PIKfyve siRNAs used in this experiment were ob-
tained from GE Healthcare, Dharmacon RNAi & Gene
expression (Lafayette, CO) as the ON-TARGET plus
Smart pool [17]. The nonspecific (NS) siRNAs used were
those described previously [18]. Efficiency of silencing the
gene was confirmed by performing Western blotting at
48 h post transfection using specific antibodies.
Antibodies, inhibitors, and soluble proteins
An antibody to DLD peptide sequence of gB (anti-DLD)
[10], rabbit antibodies to the RGD-containing sequence of
gB (anti-RGD) [19], rabbit antibodies to the C-terminal
domain in gB (anti-gB-C) [19], rabbit anti-gB antibodies
[11], and rabbit anti-gH antibodies [20] were used in this
study. Polyclonal sheep antibodies to PIKfyve (R&D sys-
tems, Minneapolis, MN) and polyclonal rabbit antibodies
to β-actin (Cell Signaling, Beverly, MA) were used in the
Western blotting experiments. Cytochalasin D (Cyto-D)
and Rac-1 inhibitor, NSC23766, purchased from Sigma-
Aldrich, St. Louis, MO were used in this study. His-
tagged, recombinant and soluble KSHV gBΔTM [21],
gBΔTM lacking the RGD (gBΔTM-RGA; referred to
as gBΔTMΔR) [21], and gBΔTM lacking the DLD
(gBΔTMΔD) [10] were expressed and purified from
Sf9 cells as per earlier studies [10]. Vascular endothelial
growth factor (VEGF) purchased from R&D Systems [18]
was used as a positive control in MTTassay.
Cloning of full length forms of recombinant gB
Clones gB/pCDNA3.1(+), gBΔR/pCDNA3.1(+), and gBΔD/
pCDNA3.1(+) encoding the full length gB (2535 bp), gB
lacking a functional RGD, and a functional DLD, respect-
ively, were used in this study. Clone gBΔR mutant was
generated by mutating one of the existing RGD amino acids
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(GAAHSRGDTFQTS; RGD sequence is in bold) of
KSHV gB to alanine (GCG) (GAAHSRGATFQTS;
alanine point mutation is bolded). The point muta-
tions within the RGD sequence of KSHV gB were
achieved by using the gB/pCDNA3.1(+) plasmid as
the dsDNA template and appropriate primers: RGA.F
forward (5’-GCGGCGCACTCGAGGGGTGCCACC
TTTCAGACGTCCAGTT-3′; bolded region depicts
the alanine point mutations to RGD, coding strand)
and RGA.R reverse (5′-AACTGGACGTCTGAAAG
GTGGCACCCCTCGAGTGCGCCGC-3′; bolded region
depicts the alanine point mutations to RGD, non-coding
strand); along with the QuikChange XL site-directed mu-
tagenesis kit (Stratagene, La Jolla, CA) to yield the gBΔR/
pCDNA3.1(+). Clone gBΔD/pCDNA3.1(+) was generated
as described above and using primers described in our
earlier study [10].
Flow cytometry
Flow cytometry was used to monitor expression of gB
and gH on the cells. The trypsinized transfected cells
were washed, incubated in growth medium at 37 °C for
30 min, centrifuged and resuspended in cold PBS. The
entire procedure was performed at +4 °C. Cells were in-
cubated with different antibodies at 4 °C for 30 min,
washed, incubated with FITC conjugated appropriate
secondary IgG at 4 °C for 30 min, washed and analysed
in a FACScan flow cytometer (Becton Dickinson) with
appropriate gating parameters.
In vitro transcription and translation
The IVT of different plasmids was performed using the
[35S]methionine and TNT-coupled rabbit reticulocyte
lysate system (Promega, Madison, WI) with canine pan-
creatic microsomal membranes according to the manu-
facturer's recommendations [11].
Wound healing migration assay
Untransfected, HeLa cells expressing different forms of
gB or gH were grown to 80–90 % confluence in a 1 %
collagen coated 24-well plates. The monolayers of cells
were wounded by performing a scratch with a sterile
1000 μl micropipette tip as described earlier [22]. Cells
were washed with DMEM, and further incubated at 37 °C
in DMEM containing 2 % FBS. Wound closure was
monitored at 16 h post scratch and imaged with a
laser-scanning LSM 510 Carl Zeiss confocal micro-
scope (Magnification, x 20 objective). The open area
(scratch) was quantified with TScratch software [23].
Transwell migration assay
A three-dimensional cell migration assay was performed
using A Transwell 8-mm permeable membrane insert
coated with a 1 % collagen solution (Millipore Corp.,
Billerica, MA). HeLa cells expressing various recombin-
ant gB proteins were cultured for 24 h in serum-free
medium. A 100 μl of 1x106 cells/ml suspension was
added to the upper chamber of 24-well Transwell plates
and complete DMEM medium (containing10% FBS) was
added to the bottom chamber and incubated at 37 °C.
At the end of 16 h incubation, the non-migrated cells on
the upper face of the membrane were removed by using
a sterile cotton swab and migrated cells on the lower
face were fixed in paraformaldehyde, permeabilized by
methanol (100 %) for 10 min, stained with crystal violet
for 30 min and quantitated by microscopy [24].
Cell adhesion assay
Cell adhesion assays were performed as per earlier
methods [21]. Maxisorp 96-well immune plates (Thermo
Scientific, Waltham, MA) were coated with 100 μl of dif-
ferent concentrations of soluble proteins overnight at 4 °C
in PBS. After three washes with sterile PBS, plates were
blocked with 1 % BSA in PBS for 2 h at 4 °C and washed
three times. HeLa cells were trypsinized and seeded into
the protein-coated wells of the plate at a concentration of
2x104 cells/well in a 100 μl volume. The plate contents
were incubated at 37 °C in a 5 % CO2 atmosphere with
100 % humidity for 1 h and washed four times with
serum-free DMEM, and the adherent cells were fixed with
4 % paraformaldehyde in PBS for 30 min at room
temperature. Adherent cells were washed and stained with
0.5 % crystal violet in water with 20 % (vol/vol) methanol
for 15 min at room temperature. After 15 min, the cells
were extensively washed in PBS, dye was extracted with
0.1 M sodium citrate and quantified by the measurement
of absorbance at 595 nm in an ELISA plate reader. In an-
other set of experiments, we incubated protein-coated
wells of the plate with respective antibodies to different
domains of gB prior to seeding cells and monitoring the
adhesion property as per above procedures.
We also performed the above described cell adhesion
assays with HeLa cells expressing gB, gBΔR, and gBΔD
on their cell membranes. The ability of membrane associ-
ated gB to support adhesion of cells was also confirmed
by incubating these cells with specific antibodies to differ-
ent integrin binding domains contained within gB for 1 h
at +4 °C prior to conducting the adhesion assay using
collagen coated wells.
Monitoring dynamic events on the cell membranes
Target cells were washed in phosphate buffered saline
(PBS) and fixed with 3.7 % formaldehyde in PBS for
10 min. The cells were permeabilized with 0.1 % Triton
X-100 in PBS for 3 min, washed in PBS, and blocked in
PBS containing 1 % bovine serum albumin (BSA).
These cells were stained with rhodamine-labeled phal-
loidin (Biotium, Hayward, CA) diluted (as per the
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manufacturer’s recommendations) in PBS for 20 min at
room temperature before being washed, mounted using
SlowFade Antifade Reagent containing DAPI (Life
Technologies, Grand Island, NY), and examined under
Nikon fluorescent microscope using appropriate filters.
The number of filopodial structures on the individual
cells observed under confocal microscope was counted
manually as described in earlier studies [25]. In another
set of experiments, permeabilized cells were sequen-
tially stained with mouse anti-Rac1 IgG2b monoclonal
antibodies (Thermo Scientific) and FITC-labeled appro-
priate secondary antibodies as per our earlier studies
[26]. Following this procedure the cells were further
stained with rhodamine-labeled phalloidin as described
above. This was conducted to appreciate the distribu-
tion of Rac1 in cells expressing different forms of gB in
terms of filopodial extensions.
Measuring active Rac1 by pull-down with GST-Pak1
Rac1/Cdc42 activation assay was done using the
Active Rac1/Cdc42 Pull-Down and Detection kit
(Thermo Scientific Pierce). The assay employs a GST-
fusion protein containing the p21-binding domain of
p21-activated protein kinase 1 (PAK1) to selectively
bind active Rac1/Cdc42 in whole cell lysates. The
active Rac1/Cdc42 from different cell lysates was de-
termined as per the manufacturer’s recommendation.
Briefly, the active Rac1/Cdc42 bound to the glutathi-
one agarose beads was quantified by immunoblot ana-
lysis using anti-Rac1 and anti-Cdc42 monoclonal
antibody (Thermo Scientific Pierce). The value for
active Rac1/Cdc42 collected on the beads was nor-
malized to the concentration of protein in the cell
lysate. On a separate immunoblot, the total Rac1 and
Cdc42 in a sample of the cell lysate was determined
and normalized to the protein concentration. The
normalized results were then expressed as the ratio of
active Rac1/Cdc42 to total Rac1/Cdc42 in the sample.
Cell proliferation assay
Cell proliferation was monitored using the 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay
that was performed according to standard procedures [27].
Each experiment was repeated three times. Cell prolifera-
tion was also conducted by the conventional cell counting
technique as per standard protocols [28].
Results
Generating clones of orf8 to express full length gB with
mutations to DLD and RGD
Full length KSHV orf8 is 2535 bp long that encodes a
845aa gB [29]. In earlier studies we had described the
generation of the full length gB protein and its
characterization [11]. In the present study, we used the
gB/pCDNA3.1(+) clone [11] to generate full length gB
lacking the RGD (gBΔR/pCDNA3.1) and DLD (gBΔD/
pCDNA3.1) domains (Fig. 1a). The gBΔR possess a RGA
instead of RGD motif while gBΔD possess a RVCSASIT-
GEAAAANLEQTC instead of RVCSASITGELFRFN-
LEQTC motif. The authenticity of the generated clones
was confirmed by sequencing. This was a crucial step to
characterize a role for DLD and RGD of gB in mediating
cell attachment and migration. The clones of gB/
pCDNA3.1, gBΔR/pCDNA3.1, gBΔD/pCDNA3.1, and
gH/pCDNA3.1 were in vitro transcribed and translated
(IVT) in the presence of the canine microsomal mem-
branes. Rabbit anti-gB antibodies were used to immuno-
precipitate gB from the IVT products. Rabbit anti-gB
antibodies specifically immunoprecipitated both the
glycosylated (126 kDa) and the non-glycosylated
(94 kDa) forms of the full length gB, gBΔR, and gBΔD
(Fig. 1b; lanes 2-4). Rabbit anti-gB antibodies did not
react significantly with IVT products generated using
empty vector (Fig. 1b; lane 1) and gH/pCDNA3.1
(Fig. 1b; lane 5). Pre-immune IgGs failed to immune
precipitate gB from any of the IVT products generated
(Fig. 1b, lanes 6-10). These results demonstrated the
authenticity of the gB clones generated as well as the
specificity of the rabbit anti-gB antibodies to immuno-
precipitate gB from the IVT products.
Full length gB lacking a functional RGD domain promotes
cell migration
Ideally, human microvascular endothelial cells-dermal
(HMVEC-d) would have been used in this study. Unfor-
tunately, we could not use them for the following three
reasons: (i) in our hands, the transfection efficiency
observed was poor [30]; (ii) these primary cells did not
do well upon performing the scratch (wound) com-
pounded by growing them in medium containing 2 %
FBS; (iii) these cells do not support repeated passages
under selection conditions [31]. In order to test the abil-
ity of gB to mediate cell migration, we utilized adherent
HeLa cells [32] primarily because these cells have been
extensively used to study cell migration compared to
HMVEC-d, HFF and 293 cells [33, 34].
HeLa cells were transfected with plasmids encoding
full length gB, gB lacking a functional RGD (gBΔR), gB
lacking a functional DLD (gBΔD), and gH. We used gH
as a control in this study; it is another glycoprotein like
gB encoded by KSHV, lacking a functional RGD motif.
These transfected cells were cultured with selection
medium for 2 months to establish HeLa cells stably ex-
pressing different forms of recombinant proteins. The
recombinant proteins were expressed on 90–95 % of
cells (on the surfaces) as monitored by flow cytometry.
Representative plots are provided showing the expres-
sion of virus encoded different forms of gB and gH on
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the surface of cells as determined by flow cytometry
(Fig. 2a). These cells were tested in wound healing assays
performed using collagen coated wells. The cells were
induced to migrate into a wound created by scratching
confluent cultures with a pipette tip to analyze the effect
of RGD and DLD domains contained within the gB in
promoting migration of cells. The open area was rapidly
covered in cells expressing gBΔR compared to those
untransfected (UT) or cells expressing gB, gBΔD, or gH
(Fig. 2b). Cells expressing empty vector did not signifi-
cantly promote cell migration (data not shown). Quanti-
fication of the wound closure is represented by the bar
diagram in Fig. 2c. These results were based on monitor-
ing cell migration at 16 h post scratch. The above results
Fig. 1 Generating KSHV gBΔD. a The diagram shows the schematic of orf8 encoding the full length gB (gB/pCDNA3.1) compared to gB lacking a
functional DLD (gBΔD/pCDNA3.1) and RGD (gBΔR/pCDNA3.1), respectively. b In vitro transcription and translation of KSHV orf8. IVT was
performed using pCDNA3.1 (lane 1, 6), gB/pCDNA3.1 (lane 2, 7), gBΔD/pCDNA3.1 (lane 3, 8), gBΔR/pCDNA3.1 (lane 4, 9), and gH/pCDNA3.1 (lane 5, 10)
using the microsomal membranes. The IVT products were immunoprecipitated using either rabbit anti-gB antibodies (lanes 1 – 5) or pre-immune IgGs
(lanes 6 – 10). The immunoprecipitates were resolved on a 10 % SDS-PAGE gels and autoradiographed. The letters ‘G’ and ‘NG’ denote glycosylated
and non-glysoylated forms of gB
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were confirmed on separate dates using an alternate pool
of cells expressing different recombinant proteins (data
not shown). Also, identical results were observed in transi-
ently transfected HUVEC cells (Additional file 1: Figure
S1b). We also monitored cell migration at 8–24 h post
scratch. The difference in cell migration between different
treatments was apparent by 12 h post scratch and was op-
timal by 16 h post scratch. By 20-24 h post scratch, the
wound in cells expressing gBΔR was completely
closed compared to cells expressing other constructs
(Additional file 1: Figure S1a). The results from
wound healing assays were further confirmed by per-
forming a three-dimensional cell migration assay with
the Transwell system (Fig. 2d). HeLa cells expressing
full length gB did not migrate; instead, HeLa cells ex-
pressing gBΔR were found to migrate more efficiently
(Fig. 2d). These data suggest the ability of gB lacking
RGD to significantly accelerate motility of HeLa cells.
A functional DLD within the gB is a necessity for the
gBΔR to promote cell migration
The gB lacking RGD but containing a fully functional
DLD mediates cell migration. Hence, in this section we
wanted to confirm the role for DLD in mediating mi-
gration of cells expressing gBΔR. This was done by
using anti-DLD antibodies to test if it could block the
migration of cells expressing gBΔR. Incubating cells
with anti-DLD antibodies compared to pre-immune
IgGs significantly lowered the ability of gBΔR to me-
diate migration of cells (Fig. 3a). We observed a dose
dependent effect of anti-DLD antibodies on blocking
migration of cells expressing gBΔR. Quantification of
the wound closure is presented in the bar diagram in
Fig. 3b. As expected, anti-DLD antibodies did not alter the
migration of cells expressing gB (Additional file 1:
Figure S2). Interestingly, 20 ng/ml of epidermal growth
factor (EGF)-induced migration of HeLa cells could not
be blocked by 50 μg/ml of anti-DLD antibodies suggesting
the selectivity of the antibodies in blocking the cell migra-
tion (data not shown). The results from wound healing
assays were further confirmed by performing a three-
dimensional cell migration assay with the Transwell sys-
tem (Fig. 3c). Incubating HeLa cells stably expressing
gBΔR with anti-DLD antibodies significantly and specific-
ally inhibited the ability of these cells to migrate. These
data suggest a key role for DLD of gB to significantly ac-
celerate motility of HeLa cells. To further authenticate the
effect of DLD in assisting migration of cells, we tested the
effect of incubating HeLa cells expressing gB, gBΔR, and
gBΔD with 60 μg/ml of anti-RGD antibodies on migra-
tion. Anti-RGD antibodies significantly enhanced migra-
tion of cells expressing gB in contrast to cells expressing
gBΔD (Fig. 3d). Anti-RGD antibodies compared to pre-
immune IgGs did not amplify the cell migration pattern
that was observed in cells expressing gBΔR (Fig. 3d).
Taken together, a functional DLD in gB is critical to
gBΔR-induced migration of cells. In order to confirm that
the wound closure in cells expressing gBΔR is due to
actual migration of cells and not cell proliferation, we
monitored proliferation of cells in untransfected cells
compared to cells expressing different forms of gB. We
monitored cell proliferation by two different methods: (i)
MTT cell proliferation assay and (ii) standard cell count-
ing technique. Results from MTT assay (Fig. 3e) and the
conventional cell counting technique (data not shown)
indicated that the proliferation of cells was not signifi-
cantly altered in cells expressing recombinant gB forms
compared to treating cells with soluble recombinant vas-
cular endothelial growth factor (VEGF). These results
further confirm that the wound closure in cells expressing
gBΔR on the surface of cell membrane is actually due to
migration and not due to an increase in proliferation.
KSHV gBΔR induces exaggerated changes on the cell
surfaces
Cell migration is a mechanically intensive cellular process
that is mediated by the dynamic assembly and contractility
of the actin cytoskeleton [35]. One of the hallmarks of cell
migration is the reorganization and remodeling of actin
cytoskeleton which are regulated by the Rho family of
small GTPases, Rho, Rac, and cdc42 [36]. Rho, Rac, and
cdc42 act in a well orchestrated manner to induce actin
(See figure on previous page.)
Fig. 2 Expression of gBΔR accelerates cell migration in wound healing assays. a HeLa cells stably expressing gB, gBΔR, gBΔD, and gH were analyzed
for the surface expression of gB and gH (respectively). This was performed by staining with pre-immune IgG (shaded purple), rabbit polyclonal anti-gB
antibodies (black outline), or rabbit polyclonal anti-gH antibodies (black outline) followed by incubation with goat anti-rabbit FITC, before examining
by FACS. The average percentage number of cells positive for the surface expression of gB and gH from three independent experiments is provided
over the marker. A representative histogram plot for each cell type is depicted. b Untransfected HeLa cells or cells expressing gB, gBΔD, gBΔR, and gH
in 24 well plates when 80-90 % confluent were scratched with a 1000 μl pipette tip. Wound closure was monitored at 16 h post scratch and imaged
with a laser-scanning LSM 510 Carl Zeiss confocal microscope (Magnification, x 20 objective). A representative image of cell migration is
provided. c All the wound healing assays performed in this study were independently repeated five times. The open area (scratch) was
quantified with TSratch software and the data represented as a histogram. d Expression of gBΔR on the surface of cells induces directional migration.
Data from Transwell migration assays showing alterations on the migration of HeLa cells through a permeable membrane in response to expression
of various recombinant gB is depicted. Columns with asterisk mark (panels c and d) denotes the value to be statistically significant (p < 0.05) by least
significant difference (LSD)
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polymerization that leads to the formation of filopodia
(protrusions), lamelipodia, and stress fibers that eventually
result in the movement of cells [37]. Hence, we attempted
to understand the activity in HeLa cells expressing gBΔR
compared to cells expressing gBΔD and gB. Compared to
mock transfected cells, cells expressing gB and gBΔD
demonstrated filopodial extensions (Fig. 4a). However,
such filopodial extensions were exaggerated multiple
times along with the appearance of lamelipodia in cells
expressing gBΔR on their cell surfaces (Fig. 4a, c). Interest-
ingly, culturing these cells expressing gBΔR in medium
supplemented with 50 μg/ml of anti-DLD IgGs signifi-
cantly reduced the appearance of these membrane activ-
ities (Fig. 4b). A widely used Rac1 inhibitor, NSC23766
[38], significantly limited the appearances of filopodia and
lamelipodia in HeLa cells expressing gBΔR (Fig. 4b).
Treating HeLa cells expressing gBΔR with cytochalasin D
(Cyto-D), a known inhibitor of actin dynamics, signifi-
cantly lowered polymerization of actin and this was also
used as a control. These results demonstrated a plausible
cause (occurrence of dynamic events on the surface of
cells) for the migration of cells expressing gBΔR compared
to those expressing gB and gBΔD.
Rac1 associated signaling is critical for gBΔR induced cell
migration
Rac1 and Cdc42 are among the main driving forces in
the formation of lamelipodial and filopodial extensions
[39–41]. These findings prompted us to investigate
whether Rac1 and Cdc42 do play a critical role in gBΔR
mediated cell migration. We first analyzed the manner
in which Rac1 and Cdc42 expression varied in HeLa
cells expressing gB, gBΔD, and gBΔR using a Rac1 and
Cdc42 pull down assay. The pull down assays demon-
strated significantly elevated levels of Rac1 and Cdc42
activity in cells expressing gBΔR compared to cells ex-
pressing gB, or gBΔD (Fig. 5a, c). The total Rac1 and
Cdc42 levels in all of the treatments were comparable
(Fig. 5a, c). The elevated levels of Rac1 and Cdc42 activ-
ity in cells expressing gBΔR was significantly lowered in
cells treated with Rac1 inhibitor (NSC23766) and Cdc42
inhibitor (Casin) when compared to cells that were
treated with PBS or DMSO, the respective vehicles for
the inhibitors (Fig. 5a-d). Between Rac1 and Cdc42, the
former has a more crucial role in mediating migration of
cells [42] and hence this study focused more on Rac1
associated signaling than Cdc42. Distribution of active
Rac1 was observed at the leading edges of the cells to
regulate localized actin polymerization and membrane
protrusions irrespective of the cells (expressing gB,
gBΔD, or gBΔR). However, the expression levels of Rac1
were pronounced in cells expressing gBΔR compared to
gB, gBΔD (Fig. 5e), and empty vector (data not shown).
We then compared the ability of the Rac1 inhibitor to
block the migration of cells induced by surface expres-
sion of gBΔR by employing the wound healing assays.
Our results demonstrated Rac1 inhibitor to signifi-
cantly block the ability of gBΔR to mediate cell mi-
gration (Fig. 6a). The Rac1 inhibitor did not alter the
ability of gB to mediate cell migration (Additional file 1:
Figure S3). Quantification of the wound closure is repre-
sented by the bar diagram in Fig. 6b. The results from
wound healing assays were further confirmed by perform-
ing a three-dimensional cell migration assay with the
Transwell system (Fig. 6c). Incubating HeLa cells express-
ing gBΔR with Rac1 inhibitor significantly inhibited the
ability of these cells to migrate compared to incubating
cells with the vehicle for the Rac1 inhibitor, PBS. We ob-
served identical results when Cdc42 inhibitor was tested
(data not shown). These data suggest a key role for Rac1
and Cdc42 associated signaling in the ability of gBΔR to
accelerate motility of HeLa cells.
Silencing the upstream effector of Rac1 signaling
significantly blocks migration of cells expressing gBΔR
Recent studies demonstrated phosphoinositide 5-kinase,
FYVE finger containing enzyme, PIKfyve, as one of the
upstream molecules known to regulate migration of cells
by activating Rac1 [43]. In order to further confirm a
role for Rac1 associated signaling, we attempted to
analyze the ability of cells expressing gBΔR to migrate
under conditions where the expression of PIKfyve was
silenced by using specific SiRNA. For this purpose, we
used HeLa cells stably expressing gBΔR (Fig. 2a). These
(See figure on previous page.)
Fig. 3 DLD of gB is critical to mediating cell migration. a, b, d HeLa cells stably expressing gB (d), gBΔR (a, b, d), or gBΔD (d) in 24 well plates
when 80-90 % confluent were scratched with a 1000 μl pipette tip. Post scratch, the cells were incubated with medium supplemented with
different concentrations of anti-DLD antibodies (a, b), anti-RGD antibodies (d) or pre-immune IgGs (PIG). Wound closure was monitored at
16 h post scratch and imaged with a laser-scanning LSM 510 Carl Zeiss confocal microscope (Magnification, x 20 objective). A representative
image of cell migration is provided (a). b, d The open area (scratch) was quantified with TSratch software and the data represented as a histogram.
c Data from Transwell migration assays showing alterations on the migration of HeLa cells expressing gBΔR through a permeable membrane
in response to incubating them with anti-DLD antibodies is depicted. e MTT cell proliferation assay was performed to monitor the effect of gB
on cells. Briefly, target cells were plated to a density of 3,000 cells/well in a 96-well plate in 150 μl volume of growth medium (DMEM supplemented
with 10 % FBS). The following day, cells were incubated with DMEM containing 2 % FBS. As a positive control, we supplemented 10 ng/ml of VEGF to
one of the wells seeded with untransfected cells. After 72 h, the MTT assay was performed. Each experiment was repeated three times. Columns with
different alphabets (panels b, c, d, and e) indicate the values to be statistically significant (p < 0.05) by LSD
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cells expressing gBΔR were untransfected, mock trans-
fected, transfected with PIKfyve SiRNA, or NS-SiRNA.
At 48 h post transfection of SiRNA, cells were analyzed
for the expression of PIKfyve by Western blotting using
specific antibodies. Transfection of HeLa cells expressing
gBΔR with PIKfyve SiRNA significantly reduced the
expression of PIKfyve (Fig. 7a). Mock transfection or
transfection of HeLa cells expressing gBΔR with NS-
Fig. 4 HeLa cells expressing gBΔR induce exaggerated changes at the edges of the cell membranes. a HeLa cells stably expressing gB, gBΔD,
and gBΔR were fixed, permeabilized, and stained for polymerized actin by rhodamine-labeled phalloidin for 20 min at room temperature, washed,
mounted using a mountant with DAPI prior to examining under a Nikon microscope using appropriate filters. b In a separate experiment, the
cells expressing gBΔR were either treated with medium supplemented with 50 μg/ml of pre-immune IgGs or anti-DLD IgGs; or treated
with 50 μM NSC23766 (Rac1 inhibitor) or 1 μM cyto-D for 2 h, prior to staining as above and viewing under the fluorescent microscope.
A representative figure of the cells under different conditions is provided at a magnification of x 100. Closed yellow arrow heads, and arrows
denote filopodial and lamelipodia, respectively. c Filopodial quantification: 300-500 μm long filopodial structures were counted on ten randomly
selected cells for each treatment and the numbers were averaged. To avoid bias, the counting of filopodial projections for each treatment
was performed by two different individuals and averaged. Each point on the plot represents the average from three different experiments.
Asterisks on the data point denote the value to be statistically significant (p˂0.05) by LSD
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SiRNA did not alter the expression of PIKfyve (Fig. 7a).
The effect of NS-SiRNA on PIKfyve expression was
comparable to what was observed in untransfected cells
(Fig. 7a). These cells were analyzed by staining for F-
actin using rhodamine-labeled phalloidin. HeLa cells
expressing gBΔR that were either untransfected or
transfected with NS-SiRNA demonstrated significant
amounts of dynamic changes on the cell membranes
including long filopodial extensions while, PIKfyve
SiRNA transfected cells expressing gBΔR only had
limited filopodial extensions (Fig. 7b). We then com-
pared the ability of silencing PIKfyve to block the
migration of cells induced by surface expression of
gBΔR. Our results demonstrated knocking down PIK-
fyve significantly blocked the ability of gBΔR to mediate
cell migration (Fig. 7c). Silencing PIKfyve did not alter the
ability of gB to mediate cell migration (Additional file 1:
Figure S4). Mock transfection or transfection of cells with
NS-SiRNA did not alter the ability of cells expressing
gBΔR to migrate. Quantification of the wound closure is
Fig. 5 Rac1/Cdc42 signaling is induced in cells expressing gBR. Rac1 (a, b) and Cdc42 (c, d) activity was measured using GST-Pak1 pulldown assays
in cells expressing gB, gBΔD, and gBΔR in the absence or in the presence of a NSC23766 (Rac1 inhibitor) and Casin (Cdc42 inhibitor). b, d The graph
shows densitometric analysis of Rac/Cdc42-GTP levels with respect to input levels of total Rac1/Cdc42 for 5 independent experiments. e Cells
expressing different forms of gB were permeabiized and double stained with anti-Rac1 (Green) and phalloidin (Red). The two images were
merged to show the co-localization (denoted by arrows). Magnification: x100
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represented by the bar diagram in Fig. 7d. The results
from wound healing assays were further confirmed by per-
forming a three-dimensional cell migration assay with the
Transwell system (Fig. 7e). HeLa cells expressing gBΔR
and those transfected with NS-SiRNA were found to
migrate more efficiently compared to cells transfected
with PIKfyve SiRNA (Fig. 7e). These data suggest a key
role for PIKfyve > Rac1 associated signaling in the ability
of gBΔR to accelerate motility of HeLa cells.
RGD is required for cell attachment
Our earlier studies utilized cell adhesion assays effect-
ively by employing soluble gB (gBΔTM) and gBΔTM
lacking a functional RGD (gBΔTMΔR) to decipher a
critical role for the RGD domain in promoting cell ad-
hesion [21]. In the present study, we analyzed the role
of DLD contained within the gB to promote adhesion
of cells by employing and comparing the effect of
gBΔTMΔD [10] with gBΔTM [10] and gBΔTMΔR [21].
Our studies demonstrated gBΔTM and gBΔTMΔD to
significantly mediate adhesion of HeLa cells when com-
pared to gBΔTMΔR and BSA (Fig. 8a).
To ascertain the specificity of HeLa cell adhesion,
gBΔTM-coated plates were preincubated with different
concentrations of IgG antibodies for 1 h at 4 °C before
seeding of HeLa cells for adhesion assays. Rabbit anti-gB
antibodies and anti-RGD antibodies significantly inhib-
ited the gBΔTM mediated adhesion of HeLa cells
(Fig. 8b). In contrast, rabbit antibodies against the gB
peptide lacking the RGD motif but with RGY amino
acids (anti-gB-C antibodies) and anti-DLD antibodies
did not show any significant inhibition of cell adhesion
(Fig. 8b). These results suggested a critical role for the
RGD and not the DLD domain of gB to mediate adhe-
sion of HeLa cells.
To authenticate these results in cells expressing gB on
their surfaces, we used HeLa cells stably expressing dif-
ferent forms of gB on the cell surfaces (Fig. 2a). In the
first experiment, we employed HeLa cells expressing gB
in adhesion assay. Our results demonstrated anti-RGD
antibodies to specifically block the adhesion of HeLa
Fig. 6 Rac1 signaling is critical for migration of cells expressing gBΔR. a HeLa cells stably expressing gBΔR in 24 well plates when 80-90 % confluent
were scratched with a 1000 μl pipette tip. After the scratch was performed, the cells were incubated with medium or medium supplemented with
50 μM of NSC23766 or vehicle (PBS). Wound closure was monitored at 16 h post scratch and imaged using a confocal microscope (Magnification, x 20
objective). A representative image of cell migration is provided. b The open area (scratch) was quantified with TSratch software and the data
represented as a histogram. c Data from Transwell migration assays showing alterations on the migration of HeLa cells expressing gBΔR
through a permeable membrane in response to incubating them with Rac1 inhibitor and the vehicle for the inhibitor (PBS) is depicted.
Columns with asterisk mark (panels b and c) denotes the value to be statistically significant (p < 0.05) by LSD
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cells expressing gB compared to anti-DLD antibodies,
anti-gH antibodies, or pre-immune IgGs (Fig. 8c). In the
next experiment, we employed HeLa cells expressing gB,
gBΔR, and gBΔD on the surface of cells. These cells
were tested for their ability to attach. There was a sig-
nificant drop in the ability of HeLa cells expressing
gBΔR to adhere compared to cells expressing gB and
gBΔD (Fig. 8d). Taken together, we conclude that the
RGD domain (and not the DLD) in gB is a necessity for
mediating adhesion of cells.
Discussion
Cell migration requires a coordinated series of events
including cell adhesion, detachment of adhesions,
Fig. 7 PIKfyve is involved in migration of cells expressing gBΔR. a Western blotting analysis demonstrating the efficient decrease in PIKfyve protein
levels after SiRNA transfection. b Fluorescent imaging demonstrating the dynamic changes on the surfaces of stably transfected HeLa cells expressing
gBΔR but transfected with PIKfyve SiRNA or NS-SiRNA compared to mock transfected cells. A representative figure of the cells under different
conditions is provided at a magnification of x100. Yellow lines denote the length and the area covered by filopodial extensions. c The migration
assay was performed in five independent experiments using cells that were either mock transfected, PIKfyve SiRNA, or NS-SiRNA transfected. d The
open area (scratch) was quantified with TSratch software and the data represented as a histogram. e Data from Transwell migration assays showing
alterations on the migration of HeLa cells expressing gBΔR that were transfected with PIKfyve SiRNA or NS-SiRNA is depicted. Columns with asterisk
mark (panels d and e) denotes the value to be statistically significant (p < 0.05) by LSD
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reorganization of the actin cytoskeleton, and membrane
protrusion and retraction [44]. The balance between cell
adhesion and detachment of adhesions is very important
for cell migration [45]. Our earlier studies identified a role
for RGD domain in gB interactions with αV integrins to en-
hance attachment of cells [12]. Taken together, we predict
gB blocks cell migration in an RGD-dependent manner by
actually increasing the cell adhesion; thus preventing cells
from migrating. These functional findings are identical to
what has been reported in a disintegrin and metalloprotease
protein family-15 (ADAM15) which, though possessing
both RGD and DLD, inhibits integrin-dependent cell mi-
gration in an RGD-dependent manner [46, 47].
KSHV gB may well be a functional homologue of the
cellular ADAM15. ADAM15 is the only ADAM member
that contains both RGD and DLD [46]. The one minor
difference between ADAM15 and gB is that ADAM15
contains RGD within its DLD while in the case of gB,
both RGD and DLD are distinctly separate domains.
Accordingly, in this study we used gB that contains two
distinct integrin binding domains (RGD and DLD) to
determine how these interactions alter the ability of a
protein to influence attachment and migration of cells.
When the first study described KSHV gB to possess a
RGD domain [19], we hypothesized gB to be a multi-
functional protein. It was based on the following facts:
Fig. 8 RGD of gB is required for attachment of cells. a KSHV gBΔTM protein-induced cell adhesion. Maxisorp plates were coated with different
concentrations of purified gBΔTM, gBΔTMΔR, gBΔTMΔD, or BSA proteins overnight at 4 °C, washed, and cell adhesion assays were carried out.
Each point on the plot represents the average from five experiments. b Antibodies to RGD inhibit the HeLa cell adhesion to gBΔTM protein.
Maxisorp plates were coated with 4 μg of purified gBΔTM protein/ml overnight at 4 °C, washed, and incubated for 1 h at 4 °C with different
antibodies prior to seeding the plate with HeLa cells and performing the cell adhesion assay. Data are presented as percentage of inhibition of cell
adhesion obtained when gBΔTM was preincubated with DMEM only. Each point on the plot represents the average from five experiments.
c Anti-RGD antibodies block the ability of gB expressed on the surfaces of HeLa cells to promote cell adhesion. HeLa cells expressing full
length gB were incubated with various antibodies for 1 h at +4 °C prior to performing cell adhesion assay in a 24-well plate. Data are
presented as percentage cell adhesion observed when cells expressing gB were preincubated with DMEM only. d gBΔR does not promote
cell adhesion. HeLa cells expressing gB, gBΔR, and gBΔD were tested in adhesion assay. Data are presented as percentage cell attachment observed
when cells expressing gB were tested. Each point on the plot represents the average from five experiments. Column with asterisk mark denotes the
value to be statistically significant (p < 0.05) by LSD
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(i) gB is expressed on the virus envelope and on the sur-
face of infected cell membranes; (ii) gB interacted with
integrins via its RGD domain; and (iii) integrins regulate
a variety of cellular functions including cell adhesion,
migration, angiogenesis, and cancer progression [48, 49].
Our studies determined gB to not only aid KSHV bind-
ing [11] and entry [19] into cells but also mediate attach-
ment of cells [12]. We were aware of the fact that RGD
and DLD domains have opposing effects [7, 50, 51].
Hence, we tested different recombinant gB proteins on
their ability to support migration of cells. In the process,
we tested full length gB instead of using soluble form of
the proteins.
Our results demonstrated gB lacking a functional RGD
domain (gBΔR) compared to the wild-type gB or gBΔD
to promote migration of cells (Fig. 2). Interestingly, cell
migration induced by gB lacking a functional RGD re-
quired a functional DLD domain (Fig. 3). Cell migration
is dependent on dynamic events like formation of filo-
podia and lamellipodia that occur on the edges of the
cell membrane [52]. In this study, we determined cells
expressing gBΔR to demonstrate exaggerated filopodial
extensions and formation of lamellipodia that could be
specifically inhibited by Rac1 inhibitor or by blocking
the DLD functions using anti-DLD IgGs (Fig. 4). The
results from the present study differed from an earlier
study which described gB to induce filopodia and la-
mellipodia [53]. This discrepancy may be due to the fact
that in the earlier study, soluble form of gB was used
compared to the physiologically relevant full length gB
tested in this study. However, the results from this study
do not in any way refute the conclusions drawn using
the soluble form of gB. Overall, the dynamic events in
terms of actin polymerization occurring on the surfaces
of the membrane are critical to supporting migration in-
duced by gBΔR.
One of the major changes that were observed in cells
expressing gBΔR was the presence of long filopodial
extensions and lamellipodia. Filopodial extensions and
lamellipodia are induced by Rac1 and cdc42-associated
signaling [35]. Active forms of Rac1 and Cdc42 were ele-
vated in cells expressing gBΔR compared to those
expressing gB, and gBΔD (Fig. 5). It is generally under-
stood that Rac1 would activate PAK, a kinase known to
phosphorylate the specific guanine nucleotide exchange
factor of Cdc42. Cdc42, in turn, will activate effectors such
as WAS, WASP or ERK, involved in the organization of
filopodia and lamellipodia [54]. Hence, we analyzed the
effect of Rac1 inhibitor on the ensuing migration of cells.
Rac1 inhibitor lowered Rac1 activity in cells expressing
gBΔR and thus the migration of those cells (Fig. 6). Recent
studies also identified a critical role for PIKfyve in indu-
cing migration of cells [43]. Silencing PIKfyve expression
in cells specifically expressing gBΔR using SiRNA
significantly inhibited expression of PIKfyve, filopodia and
lamellipodia, and migration of cells (Fig. 7). Transfection
of cells with NS-SiRNA did not significantly alter the
expression of PIKfyve, filopodia and lamellipodia, and
migration of cells. Based on these results, we concluded
the following about the RGD and DLD domains: (i) DLD
domain in gB (in the absence of RGD) induces migration
of cells via Rac1 and PIKfyve associated cell signaling; (ii)
RGD domain in gB is the switch that turns off the effect
of DLD in inducing migration of cells. In this study, we
have closely monitored the effect of cell surface expressed
different forms of gB in regulating migration versus
attachment of cells. Our future studies will focus on delin-
eating the paracrine effects of gB-induced growth factor(s)
in preferentially mediating cell attachment over migration.
The final question asked was, does DLD domain in gB
have any role to play in promoting adhesion of cells?
Our results clearly implicate a null role for DLD in
mediating cell attachment (Fig. 8). Attachment of cells is
strictly mediated by the RGD domain as described in
earlier studies [21].
The study also provides a glimpse into how the RGD
and DLD domains function as a unit to affect function
of gB. Future studies are underway to understand the
manner by which DLD and RGD-based interactions
alter RhoA, Rac1, and cdc42 in virtually promoting at-
tachment of cells over migration. This study puts forth
critical questions to better understand the manner by
which RGD domain regulates the function of DLD
within a protein in regulating migration of cells: (i)
How does DLD alter cellular signaling to promote
migration of cells; and (ii) How does RGD-induced
cellular signaling promote attachment of cells over
DLD-induced migration of cells?
Conclusion
The significance of the present study is that it demar-
cates the roles of two distinct integrin binding domains
contained within KSHV gB in modulating attachment
and migration of cells. Based on our earlier and present
studies, we propose a model where we believe RGD-
based integrin interactions that stimulate focal adhesion
kinase (FAK) activity are critical to promoting adhesion
of cells [21] while DLD-based integrin interactions that
stimulate Rac1 are crucial in promoting migration of
cells (Table 1). Increase in FAK activity has an inverse
correlation with migration of cells [55]. In terms of
Table 1 Correlation between attachment and migration of cells
to FAK and Rac1 activity
Protein gB gBΔD gBΔR Function
FAK +++ +++ + Attachment
Rac1 + + +++ Migration
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KSHV pathogenesis, gB, that possesses both the RGD
and DLD-integrin binding domains actually promote
attachment of cells compared to migration. In a way, late
structural protein gB mediates attachment of cells
thereby supporting a lytic phase of viral replication as
suggested in an earlier study [12] with a limited role in
directly promoting cancer development.
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